Randomized Double Blind Placebo Controlled Treatment of Sickle Cell Patients Hospitalized in Pain Crisis With Prophylactic Dose LMWH Versus Placebo
Phase of Trial: Phase II
Latest Information Update: 19 Feb 2015
At a glance
- Drugs Dalteparin sodium (Primary)
- Indications Deep vein thrombosis; Veno-occlusive disorders
- Focus Pharmacodynamics
- 10 Jun 2017 Biomarkers information updated
- 15 Feb 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 30 Jun 2014 Planned End Date changed from 1 Sep 2013 to 1 Jul 2014 as reported by ClinicalTrials.gov.